文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于特定气味在早期阿尔茨海默病诊断特征的简要嗅觉功能测试。

Brief Test of Olfactory Dysfunction Based on Diagnostic Features of Specific Odors in Early-Stage Alzheimer Disease.

机构信息

Clinic of Neurology an Neurosurgery, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

出版信息

Med Sci Monit. 2023 May 27;29:e940363. doi: 10.12659/MSM.940363.


DOI:10.12659/MSM.940363
PMID:37243326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10231038/
Abstract

BACKGROUND Olfactory impairment is an early symptom of Alzheimer disease (AD). However, it is rarely assessed in clinical practice. This study aimed to assess the identification and discrimination of specific odors in patients with early-stage AD using the Sniffin' Sticks test and determine the items that would be most valuable in the diagnosis of early-stage AD in order to create a brief test of olfactory dysfunction. MATERIAL AND METHODS Three groups of participants were enrolled, including 30 patients with mild cognitive impairment due to AD (MCI-AD group), 30 with mild dementia due to AD (MD-AD group), and 30 older participants with normal cognition (NC group). All participants underwent cognitive (Clinical Dementia Rating, Mini-Mental State Examination, Alzheimer's Disease Assessment Scale-Cognitive Subscale, and verbal fluency tests) and olfactory (Burghart Sniffin' Sticks odor identification and odor discrimination tests) assessments. RESULTS The MD-AD group scored significantly lower than the MCI-AD group and the MCI-AD group scored significantly lower than the NC group in both the odor identification (P<0.001) and discrimination (P<0.05) tasks. The shortened versions of the odor identification and discrimination tasks showed good diagnostic properties in differentiating patients with AD from the NC participants (receiver operating characteristic [ROC] area under the curve [AUC]=0.912 and 0.954, respectively) and differentiating patients with MCI-AD from the NC participants (ROC AUC=0.871 and 0.959, respectively). CONCLUSIONS The brief versions of olfactory tests, containing selected items that were found to differ the most between cognitively normal participants and early-stage AD patients, have good diagnostic qualities and can aid clinicians in screening for early-stage AD.

摘要

背景:嗅觉障碍是阿尔茨海默病(AD)的早期症状。然而,在临床实践中很少对其进行评估。本研究旨在使用嗅棒测试评估早期 AD 患者对特定气味的识别和辨别能力,并确定最有助于早期 AD 诊断的项目,以创建一个简短的嗅觉功能障碍测试。

材料和方法:本研究纳入了三组参与者,包括 30 名轻度认知障碍(AD 型)患者(MCI-AD 组)、30 名轻度痴呆(AD 型)患者(MD-AD 组)和 30 名认知正常的老年人(NC 组)。所有参与者均接受认知(临床痴呆评定量表、简易精神状态检查、阿尔茨海默病评估量表认知分量表和词语流畅性测试)和嗅觉(Burghart 嗅棒嗅觉识别和嗅觉辨别测试)评估。

结果:MD-AD 组在嗅觉识别(P<0.001)和辨别(P<0.05)任务中的得分均显著低于 MCI-AD 组,而 MCI-AD 组的得分又显著低于 NC 组。嗅觉识别和辨别测试的缩短版本在区分 AD 患者和 NC 参与者方面具有良好的诊断性能(受试者工作特征曲线下面积[ROC AUC]分别为 0.912 和 0.954),并在区分 MCI-AD 患者和 NC 参与者方面具有良好的诊断性能(ROC AUC 分别为 0.871 和 0.959)。

结论:包含在认知正常参与者和早期 AD 患者之间差异最大的选定项目的简短嗅觉测试版本具有良好的诊断质量,可以帮助临床医生筛查早期 AD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd1/10231038/e748e31654d6/medscimonit-29-e940363-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd1/10231038/0d5fabf33ff0/medscimonit-29-e940363-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd1/10231038/e748e31654d6/medscimonit-29-e940363-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd1/10231038/0d5fabf33ff0/medscimonit-29-e940363-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd1/10231038/e748e31654d6/medscimonit-29-e940363-g002.jpg

相似文献

[1]
Brief Test of Olfactory Dysfunction Based on Diagnostic Features of Specific Odors in Early-Stage Alzheimer Disease.

Med Sci Monit. 2023-5-27

[2]
Odor Discrimination as a Marker of Early Alzheimer's Disease.

J Alzheimers Dis. 2023

[3]
Properties of odor identification testing in screening for early-stage Alzheimer's disease.

Sci Rep. 2023-4-13

[4]
Olfactory Dysfunction Is Already Present with Subjective Cognitive Decline and Deepens with Disease Severity in the Alzheimer's Disease Spectrum.

J Alzheimers Dis. 2021

[5]
Odor Identification Screening Improves Diagnostic Classification in Incipient Alzheimer's Disease.

J Alzheimers Dis. 2017

[6]
Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.

J Neurol Sci. 2015-8-15

[7]
Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer's Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach.

J Alzheimers Dis. 2021

[8]
Olfactory impairment in mild cognitive impairment with Lewy bodies and Alzheimer's disease.

Int Psychogeriatr. 2022-6

[9]
Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.

Neurol Sci. 2018-1-30

[10]
Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.

J Neurol Sci. 2015-2-15

引用本文的文献

[1]
Diagnostic value of olfactory function testing for Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis.

Front Aging Neurosci. 2025-5-15

[2]
Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer's Disease: Effects of Polyphenols and Omega-3 Polyunsaturated Fatty Acids.

Nutrients. 2025-3-29

[3]
Olfactory Testing and Gray Matter Volume: A Combined Approach to Predict the Conversion to Alzheimer.

Brain Sci. 2025-3-15

本文引用的文献

[1]
Olfactory identification ability in patients with mild cognitive impairment and Alzheimer's disease.

J Phys Ther Sci. 2022-11

[2]
2022 Alzheimer's disease facts and figures.

Alzheimers Dement. 2022-4

[3]
Diagnostic Blood Biomarkers in Alzheimer's Disease.

Biomedicines. 2022-1-13

[4]
A novel olfactory threshold test for screening cognitive decline among elderly people.

PLoS One. 2021

[5]
Olfactory Identification in Subjective Cognitive Decline: A Meta-Analysis.

J Alzheimers Dis. 2021

[6]
Olfactory Dysfunction Is Already Present with Subjective Cognitive Decline and Deepens with Disease Severity in the Alzheimer's Disease Spectrum.

J Alzheimers Dis. 2021

[7]
Validation of Iranian Smell Identification Test for screening of mild cognitive impairment and Alzheimer's disease.

Appl Neuropsychol Adult. 2022

[8]
Psychophysical testing of smell and taste function.

Handb Clin Neurol. 2019

[9]
Screening performance of abbreviated versions of the UPSIT smell test.

J Neurol. 2019-5-3

[10]
Olfactory Dysfunction and Its Relationship with Clinical Symptoms of Alzheimer Disease.

Aging Dis. 2018-12-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索